Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor

Author: Milewicz T.   Kolodziejczyk J.   Krzysiek J.   Basta A.   Sztefko K.   Kurek S.   Stachura J.   Gregoraszczuk E. L.  

Publisher: Informa Healthcare

ISSN: 1473-0766

Source: Gynecological Endocrinology, Vol.16, Iss.4, 2002-08, pp. : 319-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content